hims hers compounded semaglutide & makes deal with Novo in obesity strategy shift Novo Nordisk sues Hims &

GLP-1 medications support the bodys natural appetite and blood sugar regulation systems

Alpha-lipoic acid improves endothelial dysfunction in patients with subclinical hypothyroidism

While GLP-1 receptor agonists such as the branded Ozempic and Mounjaro have helped revolutionise weight management, the downside of rapid weight loss is the potential to lose significant muscle mass, which can lead to diminished strength and a reduced metabolism

Been using this for over a year now its fab

The GLP-1 analogs, semaglutide and liraglutide, delay the progression of atherosclerosis by regulating inflammatory pathways in low-density lipoprotein receptor-deficient (LDLr -/- ) and apolipoprotein E-deficient (ApoE -/- ) mice [16]